Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Emergent Biosolutions
(NY:
EBS
)
9.350
+0.210 (+2.30%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Emergent Biosolutions
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
November 09, 2022
Gainers
Via
Benzinga
Emergent BioSolutions (EBS) Q3 2022 Earnings Call Transcript
November 08, 2022
EBS earnings call for the period ending September 30, 2022.
Via
The Motley Fool
FDA Issues Warning Letter For Emergent Bio's Manufacturing Facility
August 15, 2022
Via
Benzinga
Merck Partner Joins Forces With Emergent Bio To Increase Access To Ebola Treatment
July 08, 2022
Via
Benzinga
Why Emergent Bio Is Leading A Biotech Bloodbath — With Xenon Pharma Trailing
November 09, 2022
Biotech stocks were hammered Wednesday, including several that had good news.
Via
Investor's Business Daily
MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday
November 09, 2022
Via
Benzinga
Ranking the 7 Top Small-Cap Stocks to Buy From Best to Worst
October 24, 2022
Although blue chips provide greater predictability, these top small-cap stocks to buy may drive intense growth for speculators.
Via
InvestorPlace
Emergent Shares Decline Following Commencement Of Initial-Stage Lassa Virus Vaccine Candidate Study
September 06, 2022
Emergent BioSolutions (NYSE: EBS) has dosed first patient in its Phase 1 study evaluating the safety and immunogenicity of EBS-LASV in healthy subjects. EBS-LASV is a recombinant VSV-vectored Lassa...
Via
Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
Via
Benzinga
3 Top Monkeypox Stocks to Buy Right Now
August 24, 2022
With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now.
Via
InvestorPlace
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
August 23, 2022
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.
Via
Benzinga
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
August 19, 2022
Via
Benzinga
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
August 18, 2022
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.
Via
Benzinga
WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant
August 18, 2022
Via
Benzinga
A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring
August 17, 2022
Blue Water Vaccines Inc (NASDAQ: BWV)
Via
Benzinga
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
August 17, 2022
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.
Via
InvestorPlace
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand
August 17, 2022
Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide,
Via
Benzinga
WeTrade's Monkeypox Testing Kits May Go Global. Why A New Agreement Is Sending Shares Soaring Double Digits?
August 16, 2022
Via
Benzinga
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday
August 03, 2022
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.
Via
Benzinga
Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus
August 02, 2022
Via
Benzinga
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
August 02, 2022
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Via
Benzinga
Avis Budget, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday
August 02, 2022
FAT Brands Inc. (NASDAQ: FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.
Via
Benzinga
Recap: Emergent BioSolutions Q2 Earnings
August 01, 2022
Emergent BioSolutions (NYSE:EBS) reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears
August 01, 2022
Monkeypox stocks are rallying today amid worries about a shortage of vaccines for the illness in the United States.
Via
InvestorPlace
Earnings Outlook For Emergent BioSolutions
July 29, 2022
Emergent BioSolutions (NYSE:EBS) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Emergent...
Via
Benzinga
Earnings Scheduled For August 1, 2022
August 01, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Via
Benzinga
Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency
July 25, 2022
Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.
Via
InvestorPlace
WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
July 25, 2022
Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share...
Via
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile
June 29, 2022
Pharmaceutical companies that make vaccines against monkeypox are getting attention as demand for treatments against the virus grow.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.